In preclinical and in-vitro research, IGF-1 LR3 has been investigated as an agonist of the IGF-1 receptor (IGF-1R) and as a supplement in serum-free cell-culture systems
JAMA Surg 149:275287 (1992) Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement March 2527 1991
Since then, several others have followed, including dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and the latest FDA-approved medication, tirzepatide (Mounjaro, Zepbound)
In the inactive GCGR structure, ECL1 forms a -hairpin conformation and runs in parallel with the stalk to form a compact -sheet module
2024AAC03224, 2023AAC02037, 2023AAC03176, and 2022AAC03179), as well as the General Project of Scientific Research Projects in Ningxia Higher-education Institutions (grant no